A perspective on modelling hepatitis C virus infection
- 15 August 2010
- journal article
- review article
- Published by Wiley in Journal of Viral Hepatitis
- Vol. 17 (12), 825-833
- https://doi.org/10.1111/j.1365-2893.2010.01348.x
Abstract
Summary. By mathematically describing early hepatitis C virus (HCV) RNA decay after initiation of interferon (IFN)‐based antiviral therapy, crucial parameters of the in vivo viral kinetics have been estimated, such as the rate of production and clearance of free virus, and the rate of loss of infected cells. Furthermore, by suggesting mechanisms of action for IFN and ribavirin mathematical modelling has provided a means for evaluating and optimizing treatment strategies. Here, we review recent modelling developments for understanding complex viral kinetics patterns, such as triphasic HCV RNA declines and viral rebounds observed in patients treated with pegylated interferon and ribavirin. Moreover, we discuss new modelling approaches developed to interpret the viral kinetics observed in clinical trials with direct‐acting antiviral agents, which induce a rapid decline of wild‐type virus but also engender a higher risk for emergence of drug‐resistant variants. Lastly, as in vitro systems have allowed a better characterization of the virus lifecycle, we discuss new modelling approaches that combine the intracellular and the extracellular viral dynamics.Keywords
This publication has 68 references indexed in Scilit:
- Pharmacodynamics of PEG-IFN-α-2a in HIV/HCV co-infected patients: Implications for treatment outcomesJournal of Hepatology, 2010
- Rapid Emergence of Protease Inhibitor Resistance in Hepatitis C VirusScience Translational Medicine, 2010
- Effect of Ribavirin on the Mutation Rate and Spectrum of Hepatitis C Virus In VivoJournal of Virology, 2009
- Telaprevir with Peginterferon and Ribavirin for Chronic HCV Genotype 1 InfectionNew England Journal of Medicine, 2009
- A Mathematical Model of Hepatitis C Virus Dynamics in Patients With High Baseline Viral Loads or Advanced Liver DiseaseGastroenterology, 2009
- Hepatitis C viral kinetics in special populationsCurrent Hepatitis Reports, 2008
- Review: Hepatitis C Protease and Polymerase Inhibitors in DevelopmentAIDS Patient Care and STDs, 2008
- Modelling hepatitis C virus kinetics during treatment with pegylated interferon α‐2b: errors in the estimation of viral kinetic parametersJournal of Viral Hepatitis, 2007
- Modeling hepatitis C virus dynamics: Liver regeneration and critical drug efficacyJournal of Theoretical Biology, 2007
- Mathematical Modeling of Subgenomic Hepatitis C Virus Replication in Huh-7 CellsJournal of Virology, 2007